| Literature DB >> 19809514 |
K Anamika1, K R Abhinandan, K Deshmukh, N Srinivasan.
Abstract
Protein Kinase-Like Non-kinases (PKLNKs), which are closely related to protein kinases, lack the crucial catalytic aspartate in the catalytic loop, and hence cannot function as protein kinase, have been analysed. Using various sensitive sequence analysis methods, we have recognized 82 PKLNKs from four higher eukaryotic organisms, namely, Homo sapiens, Mus musculus, Rattus norvegicus, and Drosophila melanogaster. On the basis of their domain combination and function, PKLNKs have been classified mainly into four categories: (1) Ligand binding PKLNKs, (2) PKLNKs with extracellular protein-protein interaction domain, (3) PKLNKs involved in dimerization, and (4) PKLNKs with cytoplasmic protein-protein interaction module. While members of the first two classes of PKLNKs have transmembrane domain tethered to the PKLNK domain, members of the other two classes of PKLNKs are cytoplasmic in nature. The current classification scheme hopes to provide a convenient framework to classify the PKLNKs from other eukaryotes which would be helpful in deciphering their roles in cellular processes.Entities:
Year: 2009 PMID: 19809514 PMCID: PMC2754085 DOI: 10.1155/2009/365637
Source DB: PubMed Journal: Comp Funct Genomics ISSN: 1531-6912
List of 31 human PKLNKs is represented in the table. Substitutions of various important residues in the motifs which are generally conserved in the functional protein kinase are shown for each human PKLNK. “-” indicates deletion.
| Gene code | “HRD” motif in the catalytic loop | Activation loop start | Activation loop end |
|---|---|---|---|
| gi|119534|sp|P21860 | HRN | DFG | ALE |
| gi|6005792|ref|NP_009130.1 | CGS | DFA | PEE |
| gi|4758292|ref|NP_004436.1 | HRS | RLG | APE |
| gi|4758606|ref|NP_004508.1 | PRH | - - - | APE |
| gi|14042287|dbj|BAB55185.1 | HGN |
| APE |
| gi|15779207|gb|AAH14662.1 | HNN | - - G | APE |
| gi|7020363|dbj|BAA91097.1 | YGH | DLE | - - - |
| gi|7243101|dbj|BAA92598.1 | HGN | GFD | APE |
| gi|4504217|ref|NP_000171.1 | HGR | DHG | APE |
| gi|14041796|dbj|BAB55454.1 | HNN | - - G | A - - |
| gi|18676872|dbj|BAB85045.1 | HRA | KFG | APE |
| gi|17368698|sp|Q9BXU1 | HGS | DF D | APE |
| gi|18386335|gb|AAB19934.2 | HGR | DFG | APE |
| gi|12052916|emb|CAB66632.1 | HRN | DFH | - - - |
| gi|22760572|dbj|BAC11248.1 | HRN | DFH | APE |
| gi|4580422|ref|NP_003986.2 | HGS | DYG | APE |
| gi|13027388|ref|NP_061041.2 | HRS | - - G | SPE |
| gi|22749323|ref|NP_689862.1 | HGK | GFE | SP |
| gi|22760645|dbj|BAC11278.1 | HRN | DFH | APE |
| gi|16306492|ref|NP_203698.1 | Deletion | - - - | SPE |
| gi|115430241 | HNN | - - G | A - - |
| gi|134152694 | HGR | DYG | APE |
| gi|31982929 | - - - | GYG | SMD |
| gi|34191428 | HRN | D - - | APE |
| gi|40254426 | HGN | DYG | APE |
| gi|57997202 | HR | SPG | APE |
| gi|58530886 | HSN | - - - | PED |
| ENSP00000222246 | HGN | DPG | APE |
| ENSP00000264818 | HGN | DPG | APE |
| ENSP00000294423 | HGN | DPG | APE |
| ENSP00000371067 | HGN | DPG | PPE |
List of 18 drosophila PKLNKs. Substitutions of various important residues in the motifs which are generally conserved in the functional protein kinase are shown for each drosophila PKLNK. “-” indicates deletion.
| Gene code | “HRD” motif in the catalytic loop | Activation loop start | Activation loop end |
|---|---|---|---|
| gi|17368346|sp|P83097 | HRQ | VFG | APE |
| gi|21626698|gb|AAF47134.2 | HMG | DFG | SPE |
| gi|17862032|gb|AAL39493.1 | HGS | NFS | APE |
| gi|7301824|gb|AAF56933.1 | HNN | - - - | SPE |
| gi|7291217|gb|AAF46649.1 | HGK | DFG | - - - |
| gi|7294467|gb|AAF49811.1 | HGA | DFG | APE |
| gi|21357711|ref|NP_647767.1 | - - - | - - - | - - - |
| gi|5052670|gb|AAD38665.1 | HGN | - - - | APE |
| gi|21627748|gb|AAM68879.1 | YGH | - - - | AIE |
| gi|22945875|gb|AAN10635.1 | HGH | - - G | - - - |
| gi|23093524|gb|AAN11824.1 | HGA | DFG | APE |
| gi|23171402|gb|AAF55244.2 | HGN | DFG | APE |
| gi|21358011|ref|NP_651655.1 | HRN | DFC | APE |
| gi|113194917|gb|AAF51744.3 | - - - | DLG | APE |
| gi|24667933|ref|NP_525001.2 | H - - | - - - | SPE |
| gi|28380344|gb|AAF53079.3 | HGN | DFG | APE |
| gi|45446806|gb|AAF45995.2 | - - - | - - - | APE |
| gi|24641273 | HNY | DPG | RNL |
List of 13 rat PKLNKs. Substitutions of various important residues in the motifs which are generally conserved in the functional protein kinase are shown for each rat PKLNK. “-” indicates deletion.
| Gene code | “HRD” motif in the catalytic loop | Activation loop start | Activation loop end |
|---|---|---|---|
| gi|19173772|ref|NP_596900.1 | PRH | - - - | APE |
| gi|13027458|ref|NP_076490.1 | HRN | DFH | APE |
| gi|16758684|ref|NP_446283.1 | HGR | DYG | APE |
| gi|477540|pir||A49183 | HGN | DYG | APE |
| gi|13242283|ref|NP_077356.1 | HGR | DHG | APE |
| gi|204270|gb|AAA41202.1 | HGN | DYG | APE |
| gi|18543337|ref|NP_570093.1 | HGR | DHG | APE |
| gi|16758694|ref|NP_446290.1 | HGS | DYG | APE |
| gi|109476840|ref|XP_001061647.1 | HGN | DPG | APE |
| gi|149044565|gb|EDL97824.1 | HGN | DPG | APE |
| gi|2288925|emb|CAA04187.1 | HGN | DLG | APE |
| gi|2499669|sp|Q62689.1 | HGN | DPG | PPE |
| gi|2499671|sp|Q63272.1 | HGN | DPG | APE |
List of 20 mouse PKLNKs. Substitutions of various important residues in the motifs which are generally conserved in the functional protein kinase are shown for each mouse PKLNK. “-” indicates deletion.
| Gene code | “HRD” motif in the catalytic loop | Activation loop start | Activation loop end |
|---|---|---|---|
| gi|12839087|dbj|BAB24429.1 | HRL | DFG | CPE |
| gi|21594381|gb|AAH31924.1 | HRA | RLG | APE |
| gi|21703091|gb|AAM74471.1 | HGN | - - - | - - - |
| gi|21704242|ref|NP_663596.1 | HRN | DFH | APE |
| gi|21707860|gb|AAH34064.1 | HGR | DFG | APE |
| gi|12858445|dbj|BAB31320.1 | HRN | GFE | SPE |
| gi|20829352|ref|XP_129532.1 | HNN | - - G | SPE |
| gi|12963867|ref|NP_076401.1 | HNN | - - G | PPE |
| gi|20349229|ref|XP_111982.1 | HGR | DYG | APE |
| gi|20826487|ref|XP_131378.1 | HGS | DYG | APE |
| gi|20895826|ref|XP_139682.1 | - - - | DFG | APQ |
| gi|20869393|ref|XP_127567.1 | YGH | D LE | - - - |
| gi|158635954|ref|NP_113563.2 | HRS | - - - | APE |
| gi|159110415|ref|NP_032218.2 | HGR | DHG | APE |
| gi|28529710|ref|XP_142224.2 | HGR | DYG | APE |
| gi|28804246|emb|CAD29448.2 | CGN | DFA | PEE |
| gi|111607496|ref|NP_666257.2 | HGN | DPG | APE |
| gi|114326478|ref|NP_001041642.1 | HGN | DPG | PPE |
| gi|133922607|ref|NP_061263.2 | HGN | DPG | APE |
| gi|156630890|sp|Q62137.2 | HGN | DPG | APE |
List of PKLNK analysed. Information on number of residues and the nearest protein kinase subfamily to which they belong to has also been provided. Abbreviations followed in the table are RGC, Receptor guanylate cyclase; CAMK1, Ca2+/Calmodulin dependent protein kinase 1; TSSK, Testis-specific serine/Threonine kinase; MLCK, Myosin light chain kinase; Eph, Ephrin receptor; EGFR, Epidermal growth factor receptor; JakA, Janus kinase A; MLK, Mixed lineage kinase; Slob, SLOw Border; NRBP, Nuclear receptor binding protein; TBCK, TBC domain-containing kinase; VRK, Vaccinia-related kinase; IRAK, IL1 receptor associated kinase; CDK, Cyclin dependent kinase; MAPK, Mitogen activated kinase; WNK, With no K (Lysine).
| PKLNK gene accession code | Number of residues | Closest subfamily of protein kinase |
|---|---|---|
| gi|40254426|ref|NP_000897.2| | 1061 | RGC |
| gi|477540|pir||A49183 | 333 | RGC |
| gi|4580422|ref|NP_003986.2| | 1047 | RGC |
| gi|20826487|ref|XP_131378.1| | 477 | RGC |
| gi|16758694|ref|NP_446290.1| | 1047 | RGC |
| gi|204270|gb|AAA41202.1| | 1057 | RGC |
| gi|23093524|gb|AAN11824.1|AE003537_3 | 1272 | RGC |
| gi|7294467|gb|AAF49811.1| | 1172 | RGC |
| gi|7291217|gb|AAF46649.1| | 1076 | RGC |
| gi|23171402|gb|AAF55244.2| | 1417 | RGC |
| gi|4504217|ref|NP_000171.1| | 1103 | RGC |
| gi|159110415|ref|NP_032218.2| | 1108 | RGC |
| gi|13242283|ref|NP_077356.1| | 1108 | RGC |
| gi|134152694|ref|NP_001513.2| | 1108 | RGC |
| gi|28529710|ref|XP_142224.2| | 1372 | RGC |
| gi|20349229|ref|XP_111982.1| | 625 | RGC |
| gi|16758684|ref|NP_446283.1| | 1108 | RGC |
| gi|18543337|ref|NP_570093.1| | 1110 | RGC |
| gi|28380344|gb|AAF53079.3| | 1163 | RGC |
| gi|18386335|gb|AAB19934.2| | 1073 | RGC |
| gi|21707860|gb|AAH34064.1| | 754 | RGC |
| gi|22760572|dbj|BAC11248.1| | 501 | CAMK1 |
| gi|22760645|dbj|BAC11278.1| | 470 | CAMK1 |
| gi|12052916|emb|CAB66632.1| | 473 | CAMK1 |
| gi|21704242|ref|NP_663596.1| | 512 | CAMK1 |
| gi|13027458|ref|NP_076490.1| | 504 | CAMK1 |
| gi|12839087|dbj|BAB24429.1| | 292 | TSSK |
| gi|21626698|gb|AAF47134.2| | 3197 | MLCK |
| gi|4758292|ref|NP_004436.1| | 1006 | Eph |
| gi|21594381|gb|AAH31924.1| | 1014 | Eph |
| gi|17368346|sp|P83097|WSCK_DROME | 809 | Eph |
| gi|119534|sp|P21860.1|ERBB3_HUMAN | 1342 | EGFR |
| gi|24641273 | 1177 | JakA |
| ENSP00000294423 | 1156 | JakA |
| gi|133922607|ref|NP_061263.2| | 1184 | JakA |
| gi|111607496|ref|NP_666257.2| | 1153 | JakA |
| gi|149044565|gb|EDL97824.1| | 1153 | JakA |
| gi|109476840|ref|XP_001061647.1| | 1198 | JakA |
| gi|2288925|emb|CAA04187.1| | 866 | JakA |
| ENSP00000371067 | 1132 | JakA |
| gi|114326478|ref|NP_001041642.1| | 1132 | JakA |
| gi|2499669|sp|Q62689.1|JAK2_RAT | 1132 | JakA |
| gi|156630890|sp|Q62137.2|JAK3_MOUSE | 1100 | JakA |
| gi|2499671|sp|Q63272.1|JAK3_RAT | 1100 | JakA |
| ENSP00000222246 | 1131 | JakA |
| ENSP00000264818 | 1187 | JakA |
| gi|5052670|gb|AAD38665.1|AF145690_1 | 637 | NRBP |
| gi|14042287|dbj|BAB55185.1| | 535 | NRBP |
| gi|21358011|ref|NP_651655.1| | 835 | SCY1 |
| gi|7301824|gb|AAF56933.1| | 873 | SCY1 |
| gi|14041796|dbj|BAB55454.1| | 707 | SCY1 |
| gi|115430241|ref|NP_065731.3| | 808 | SCY1 |
| gi|12963867|ref|NP_076401.1| | 806 | SCY1 |
| gi|15779207|gb|AAH14662.1| | 688 | SCY1 |
| gi|7243101|dbj|BAA92598.1| | 796 | SCY1 |
| gi|20829352|ref|XP_129532.1| | 735 | SCY1 |
| gi|113194917|gb|AAF51744.3| | 2352 | WNK |
| gi|21627748|gb|AAM68879.1| | 646 | Slob |
| gi|22945875|gb|AAN10635.1|AE003618_7 | 638 | Slob |
| gi|7020363|dbj|BAA91097.1| | 649 | Slob |
| gi|20869393|ref|XP_127567.1| | 582 | Slob |
| gi|45446806|gb|AAF45995.2| | 819 | TBCK |
| gi|18676872|dbj|BAB85045.1| | 893 | TBCK |
| gi|31982929|ref|NP_057524.2| | 474 | VRK |
| gi|21703091|gb|AAM74471.1| | 453 | VRK |
| gi|24667933|ref|NP_525001.2| | 448 | MLK |
| gi|4758606|ref|NP_004508.1| | 452 | MLK |
| gi|19173772|ref|NP_596900.1| | 452 | MLK |
| gi|58530886|ref|NP_001561.3| | 625 | IRAK |
| gi|6005792|ref|NP_009130.1| | 596 | IRAK |
| gi|28804246|emb|CAD29448.2| | 609 | IRAK |
| gi|12858445|dbj|BAB31320.1| | 472 | Dicty4 |
| gi|22749323|ref|NP_689862.1| | 471 | Dicty4 |
| gi|16306492|ref|NP_203698.1| | 240 | CDK |
| gi|20895826|ref|XP_139682.1| | 216 | MAPK |
| gi|17862032|gb|AAL39493.1| | 346 | STE20 |
| gi|13027388|ref|NP_061041.2| | 418 | STE20 |
| gi|17368698|sp|Q9BXU1|STK31_HUMAN | 1019 | Unclassified protein kinase |
| gi|21357711|ref|NP_647767.1| | 790 | Unclassified protein kinase |
| gi|34191428|gb|AAH36504.2| | 700 | Unclassified protein kinase |
| gi|57997202|emb|CAD38856.2| | 1491 | Unclassified protein kinase |
| gi|158635954|ref|NP_113563.2| | 1450 | Unclassified protein kinase |
Figure 1Phylogenetic tree representing catalytic kinase domain and PKLNK domains of mouse. Abbreviations followed in the figure are Pkinase, Protein kinase; PKLNK, Protein kinase-like nonkinase.
List of 82 PKLNKs identified from human, mouse, rat, and drosophila. Their gene accession code and domain architecture are also provided. Abbreviations followed in the table are SH2, Src homology 2; PKLNK, Protein kinase-like nonkinase, Pkinase, Protein kinase; Guanylate_cyc, Guanylate cyclase; TM, Transmembrane; Ank, Ankyrin; SAM, Sterile alpha motif; PX, Phox; I-set, Immunoglobulin; fn3, Fibronectin type III; Ephrin_lbd, Ephrin receptor ligand binding domain.
| Gene accession code | Domain name, boundary, and E-value |
|---|---|
| ENSP00000222246 | SH2, 377 457 0.0066 * PKLNK, 822 1071 2e-27 * |
| ENSP00000264818 | PKLNK, 589 866 4.9e-10 * Pkinase, 897 1172 1.2e-44 * |
| ENSP00000294423 | SH2, 441 526 0.0016 * PKLNK, 583 847 1e-12 * Pkinase, 877 1151 2.1e-40 * |
| ENSP00000371067 | SH2, 401 481 0.00012 * PKLNK, 545 805 2.6e-10 * Pkinase, 849 1123 4.4e-42 * |
| gi|109476840|ref|XP_001061647.1| | SH2, 486 570 0.0016 * PKLNK, 627 889 1.5e-12 * Pkinase, 919 1193 3.5e-39 * |
| gi|111607496|ref|NP_666257.2| | SH2, 441 525 0.0038 * PKLNK, 582 844 1.8e-12 * Pkinase, 874 1148 4.5e-39 * |
| gi|113194917|gb|AAF51744.3| | PKLNK, 444 650 2.4e-21 * |
| gi|114326478|ref|NP_001041642.1| | SH2, 401 481 0.00014 * PKLNK, 545 805 1.5e-09 * Pkinase, 849 1123 5.2e-43 * |
| gi|115430241|ref|NP_065731.3| | PKLNK, 29 259 4e-88 * HEAT, 383 419 0.0067 * HEAT, 501 537 3.2e-05 * |
| gi|119534|sp|P21860.1|ERBB3_HUMAN | Recep_L_domain, 55 167 6.7e-45 * Furin-like, 180 332 3.4e-79 * Recep_L_domain, 353 474 3.4e-46 * TM, o644 666i * PKLNK, 709 965 1.9e-24 * |
| gi|12052916|emb|CAB66632.1| | PKLNK, 24 258 2.2e-38 * |
| gi|12839087|dbj|BAB24429.1| | PKLNK, 25 289 6e-55 * |
| gi|12858445|dbj|BAB31320.1| | PKLNK, 195 461 5e-11 * |
| gi|12963867|ref|NP_076401.1| | PKLNK, 29 301 0.00098 * HEAT, 383 419 0.014 * HEAT, 501 537 0.00015 * |
| gi|13027388|ref|NP_061041.2| | PKLNK, 58 369 2e-28 * |
| gi|13027458|ref|NP_076490.1| | PKLNK, 24 286 9.9e-70 * |
| gi|13242283|ref|NP_077356.1| | ANF_receptor, 75 411 5.3e-59 * TM, o468 490i * PKLNK, 520 808 1.8e-09 * Guanylate_cyc, 874 1061 2.2e-92 * |
| gi|133922607|ref|NP_061263.2| | PKLNK, 589 863 1.7e-10 * Pkinase, 894 1166 4.5e-43 * |
| gi|134152694|ref|NP_001513.2| | ANF_receptor, 71 412 3.1e-83 * TM, o468 490i * PKLNK, 532 809 3.1e-14 * Guanylate_cyc, 875 1062 3.4e-92 * |
| gi|14041796|dbj|BAB55454.1| | PKLNK 29 259 9e-89 * HEAT, 383 419 0.0067 * HEAT, 501 537 3.2e-05 * |
| gi|14042287|dbj|BAB55185.1| | PKLNK, 81 327 3.2e-08 * |
| gi|149044565|gb|EDL97824.1| | SH2, 441 525 0.0016 * PKLNK, 582 844 1.5e-12 * Pkinase, 874 1148 3.5e-39 * |
| gi|156630890|sp|Q62137.2|JAK3_MOUSE | PKLNK, 818 1091 2.1e-37 * |
| gi|15779207|gb|AAH14662.1| | PKLNK, 18 245 0.00017 * |
| gi|58635954|ref|NP_113563.2| | Ank, 55 87 0.00011 * Ank, 88 120 0.018 * PKLNK, 251 503 2e-06 * |
| gi|159110415|ref|NP_032218.2| | ANF_receptor, 75 411 1.1e-56 * TM, o345 364i * PKLNK, 520 811 2.3e-09 * Guanylate_cyc, 874 1061 7e-92 * |
| gi|16306492|ref|NP_203698.1| | PKLNK, 4 230 8.7e-56 * |
| gi|16758684|ref|NP_446283.1| | ANF_receptor, 71 412 2.8e-74 * TM, o468 490i * PKLNK, 532 809 8.6e-11 * Guanylate_cyc, 875 1062 2.2e-92 * |
| gi|16758694|ref|NP_446290.1| | ANF_receptor, 44 400 5.9e-75 * TM, o456 478i * PKLNK, 534 786 5.3e-17 * Guanylate_cyc, 852 1038 5.6e-107 * |
| gi|17368346|sp|P83097|WSCK_DROME | TM, i12 34o * WSC, 42 115 3.8e-25 * fn3, 129 233 2e-05 * TM, o422 444i * PKLNK, 511 768 2.6e-10 * |
| gi|17368698|sp|Q9BXU1|STK31_HUMAN | TUDOR, 28 147 2e-31 * PKLNK, 739 972 3.6e-05 * |
| gi|17862032|gb|AAL39493.1| | PKLNK, 10 298 3.7e-11 * |
| gi|18386335|gb|AAB19934.2| | ANF_receptor, 53 386 3.9e-32 * TM, o432 454i * PKLNK, 497 745 1.1e-09 * Guanylate_cyc, 815 1002 1.5e-104 * |
| gi|18543337|ref|NP_570093.1| | ANF_receptor, 88 422 7e-71 * TM, o480 502i * PKLNK, 550 818 2.4e-11 * Guanylate_cyc, 884 1071 1.4e-90 * |
| gi|18676872|dbj|BAB85045.1| | PKLNK, 26 273 3.4e-18 * TBC, 463 673 1.1e-10 * Rhodanese, 776 883 9.2e-09 * |
| gi|19173772|ref|NP_596900.1| | Ank, 33 65 9.4e-09 * Ank, 66 98 1.6e-09 * Ank, 99 131 3.2e-07 * PKLNK, 193 449 1.5e-10 * |
| gi|20349229|ref|XP_111982.1| | PKLNK, 1 214 2e-08 * Guanylate_cyc, 306 521 1.2e-79 * |
| gi|204270|gb|AAA41202.1| | ANF_receptor, 50 412 1.3e-80 * PKLNK, 534 797 8.4e-13 * Guanylate_cyc, 863 1049 6e-109 * |
| gi|20826487|ref|XP_131378.1| | PKLNK, 1 216 7e-09 * Guanylate_cyc, 282 468 5.6e-107 * |
| gi|20829352|ref|XP_129532.1| | PKLNK, 18 245 8.9e-05 * |
| gi|20869393|ref|XP_127567.1| | PX, 17 122 2.4e-19 * PKLNK, 146 443 0.0012 * |
| gi|20895826|ref|XP_139682.1| | PKLNK, 4 206 3.7e-06 * |
| gi|21357711|ref|NP_647767.1| | PKLNK, 406 658 0.0018 * |
| gi|21358011|ref|NP_651655.1| | PKLNK, 31 314 5.7e-09 * |
| gi|21594381|gb|AAH31924.1| | TM, i13 32o * Ephrin_lbd, 34 227 4.5e-113 * fn3, 365 463 1.8e-06 * fn3, 481 565 1.3e-17 * TM, o590 612i * PKLNK, 663 908 7.4e-22 * SAM, 938 1005 1.6e-22 * |
| gi|21626698|gb|AAF47134.2| | I-set, 2 87 2.1e-06 * I-set, 102 195 6.9e-17 * I-set, 203 278 0.00011 * I-set, 292 382 7.6e-23 * I-set, 385 479 2.6e-05 * I-set, 483 574 2.6e-15 * I-set, 578 669 6.2e-11 * I-set, 673 765 7.1e-20 * I-set, 800 884 3.1e-10 * I-set, 893 993 0.00015 * I-set, 997 1087 2.5e-10 * I-set, 1092 1194 1.3e-05 * I-set, 1199 1290 2.1e-21 * I-set, 1297 1387 7.4e-24 * I-set, 1394 1485 7.3e-23 * I-set, 1498 1587 4.6e-21 * I-set, 1594 1683 1.1e-18 * I-set, 1696 1786 1.1e-21 * fn3, 1812 1898 9.9e-07 * I-set, 1951 2042 0.00043 * I-set, 2046 2136 7.1e-12 * PKLNK, 2165 2419 2.5e-48 * I-set, 2633 2723 1.2e-17 * fn3, 2727 2809 1.2e-12 * PKLNK, 2876 3130 1.7e-34 * |
| gi|21627748|gb|AAM68879.1| | PX, 17 122 7.9e-15 * PKLNK, 146 435 0.00023 * |
| gi|21703091|gb|AAM74471.1| | PKLNK, 145 439 e-128 * |
| gi|21704242|ref|NP_663596.1| | PKLNK, 24 286 3.4e-70 * |
| gi|21707860|gb|AAH34064.1| | TM, o114 136i * PKLNK, 176 426 3.7e-10 *Guanylate_cyc, 496 683 2e-99 * |
| gi|22749323|ref|NP_689862.1| | PKLNK, 209 466 1e-13 * |
| gi|22760572|dbj|BAC11248.1| | PKLNK, 24 286 7.8e-67 * |
| gi|22760645|dbj|BAC11278.1| | PKLNK, 24 286 3.4e-70 * |
| gi|2288925|emb|CAA04187.1| | SH2, 313 397 0.00056 * PKLNK, 454 716 3.2e-14 * |
| gi|22945875|gb|AAN10635.1|AE003618_7 | PKLNK, 304 520 * |
| gi|23093524|gb|AAN11824.1|AE003537_3 | ANF_receptor, 64 447 8e-33 * PKLNK, 610 869 4.4e-16 * Guanylate_cyc, 935 1121 1.5e-89 * |
| gi|23171402|gb|AAF55244.2| | ANF_receptor, 107 473 1.2e-83 * PKLNK, 608 877 1.8e-15 * Guanylate_cyc, 944 1130 9.7e-103 * |
| gi|24667933|ref|NP_525001.2| | Ank, 33 65 1.6e-07 * Ank, 66 98 1.4e-06 * Ank, 99 131 1.5e-08 * PKLNK, 192 446 6.9e-09 * |
| gi|2499669|sp|Q62689.1|JAK2_RAT | SH2, 401 481 8.6e-05 * PKLNK, 545 805 8.9e-10 * Pkinase, 849 1123 1.9e-43 * |
| gi|2499671|sp|Q63272.1|JAK3_RAT | PKLNK, 818 1091 2.7e-38 * |
| gi|28380344|gb|AAF53079.3| | ANF_receptor, 57 398 2e-37 * PKLNK, 529 798 3e-11 * Guanylate_cyc, 864 1050 3.3e-88 * |
| gi|28529710|ref|XP_142224.2| | ANF_receptor, 166 499 3.7e-62 * PKLNK, 647 926 1.5e-10 * Guanylate_cyc, 1018 1229 2.4e-72 * |
| gi|28804246|emb|CAD29448.2| | Death, 26 106 5.1e-18 * PKLNK, 178 456 1e-17 * |
| gi|31982929|ref|NP_057524.2| | PKLNK, 202 460 0.0082 * |
| gi|34191428|gb|AAH36504.2| | PKLNK, 48 317 7.9e-14 * |
| gi|40254426|ref|NP_000897.2| | ANF_receptor, 54 416 2.7e-79 * PKLNK, 538 801 3.7e-11 * Guanylate_cyc, 867 1053 7e-110 * |
| gi|4504217|ref|NP_000171.1| | ANF_receptor, 72 408 1.3e-55 * TM, o465 487i* PKLNK, 517 805 8.8e-10 * HNOBA, 718 870 0.009 * Guanylate_cyc, 871 1058 1.8e-89 * |
| gi|45446806|gb|AAF45995.2| | PKLNK, 18 263 1.2e-07 * TBC, 430 636 1.4e-08 * |
| gi|4580422|ref|NP_003986.2| | ANF_receptor, 44 400 2.7e-75 * PKLNK, 534 786 3.2e-18 * Guanylate_cyc, 852 1038 5.6e-107 * |
| gi|4758292|ref|NP_004436.1| | Ephrin_lbd, 18 217 4.5e-110 * fn3, 355 455 1.8e-06 * fn3, 473 557 3.2e-18 * TM, o582 604i * PKLNK, 655 900 1.1e-22 * SAM, 930 997 6e-22 * |
| gi|4758606|ref|NP_004508.1| | Ank, 33 65 9.4e-09 * Ank, 66 98 1.6e-09 * Ank, 99 131 3.2e-07 * PKLNK, 193 449 1.3e-10 * |
| gi|477540|pir||A49183 | PKLNK, 16 250 7.9e-07 * |
| gi|5052670|gb|AAD38665.1|AF145690_1 | PKLNK, 122 375 4.7e-09 * |
| gi|57997202|emb|CAD38856.2| | Ank, 55 87 0.0025 * Ank, 88 120 0.0056 * PKLNK, 251 503 1.6e-06 * |
| gi|58530886|ref|NP_001561.3| | Death, 14 94 2.9e-16 * PKLNK, 210 496 2.6e-11 * |
| gi|6005792|ref|NP_009130.1| | Death, 26 106 4.4e-18 * PKLNK, 165 443 3e-12 * |
| gi|7020363|dbj|BAA91097.1| | PX, 17 122 1.3e-16 * PKLNK, 146 449 0.0028 * |
| gi|7243101|dbj|BAA92598.1| | PKLNK, 4 190 2e-63 * |
| gi|7291217|gb|AAF46649.1| | ANF_receptor, 107 481 1.4e-73 * PKLNK, 555 794 3.9e-10 * Guanylate_cyc, 860 1046 1.2e-99 * |
| gi|7294467|gb|AAF49811.1| | ANF_receptor, 64 423 3.9e-35 * PKLNK, 573 832 4.4e-16 * Guanylate_cyc, 898 1084 1.5e-89 * |
| gi|7301824|gb|AAF56933.1| | PKLNK, 28 268 2e-82 * HEAT, 383 419 0.0027 * |
| gi|24641273 | PKLNK, 892 1151 1.4e-35 * |
Frequency of domain families tethered to the PKLNKs.
| Domain name | Number of gene products | Number of domains |
|---|---|---|
| ANF receptor | 17 | 17 |
| Guanylate cyclase | 20 | 20 |
| Protein kinase | 9 | 9 |
| Ankyrin | 5 | 13 |
| Fibronectin 3 | 4 | 7 |
| Heat | 4 | 7 |
| Immunoglobulin I-set | 1 | 21 |
| Phox | 3 | 3 |
| TBC | 2 | 2 |
| Receptor L domain | 1 | 2 |
| Furin-like | 1 | 1 |
| Death | 3 | 3 |
| Ephrin receptor ligand binding domain | 2 | 2 |
| Sterile Alpha Motif | 2 | 2 |
| WSC | 1 | 1 |
| Rhodanese | 1 | 1 |
| Tudor | 1 | 1 |
| Transmembrane domain | 13 | 15 |
Figure 2Unique domain architectures which are present in PKLNK and so far not reported in the protein kinase. Abbreviations followed in the figure are I-set, Immunoglobulin I-set; fn3, Fibronectin 3; PKLNK, Protein Kinase-Like Nonkinase.
Figure 3The dendrogram generated by considering the nonenzymatic protein kinase-like nonkinase domains. Various sequences having similar domain organization are represented in different colours: Green: PKLNK having Guanylate Cyclase (GC) domain in the C-terminus; Pink: Ankyrin repeat tethered to the PKLNK; Cyan: Ephrin_lbd, fn3, SterilAlpha Motif (SAM) tethered to the PKLNK; Purple: Death domain tethered to the PKLNK; Blue: Phox (PX) domain tethered to the PKLNK; Brown: Heat domain tethered to the PKLNK; Red: Src Homology 2 (SH2) tethered to the PKLNK.
Common and unique domain structures of PKLNKs and protein kinases encoded in the data set of genomes. Abbreviations followed in the table are Mad3_BUB1_I, Mad3/BUB1 homology region 1; Pkinase, Protein kinase; PKLNK, Protein kinase-like nonkinase; TM, Transmembrane; SH2, Src-homology 2; I-set, Immunoglobulin; Ank, Ankyrin; fn3, Fibronectin type III; Ephrin_lbd, Ephrin receptor ligand binding domain; SAM, Sterile alpha motif; HNOBA, Heme NO binding associated; Guanylate_cyc, Guanylate cyclase.
| Domain structure unique to PKLNKs | Domain structure unique to protein kinases | Domain structure common to protein kinases and PKLNKs |
|---|---|---|
| PKLNK, HEAT × 2 | TM, ANF_receptor, Pkinase, Guanylate_cyc | SH2, PKLNK, Pkinase |
| Ank × 2, PKLNK | I-set × 2, Pkinase | Recep_L_domain, Furin-like, Recep_L_domain, TM, PKLNK |
| TUDOR, PKLNK | Mad3_BUB1_I, Pkinase | PKLNK, Pkinase |
| ANF_receptor, TM, PKLNK, HNOBA, Guanylate_cyc | Ank × 3, Pkinase | TM, WSC, fn3, TM, PKLNK |
| ANF_receptor, TM, PKLNK, Guanylate_cyc | ||
| PKLNK, TBC, Rhodanese | ||
| PKLNK, Guanylate_cyc | ||
| TM, Ephrin_lbd, fn3 × 2, TM, PKLNK, SAM | ||
| I-set × 18, fn3, I-set × 2, PKLNK, I-set, fn3, PKLNK | ||
| TM, PKLNK, Guanylate_cyc | ||
| SH2, PKLNK | ||
| ANF_receptor, PKLNK, Guanylate_cyc | ||
| PKLNK, TBC | ||
| Ephrin_lbd, fn3 × 2, TM, PKLNK, SAM | ||
| Death, PKLNK | ||
| PX, PKLNK | ||
| PKLNK, HEAT |
List of PKLNKs which interact with a large number of proteins. The in vivo/in vitro protein-protein interaction data has been obtained from HPRD database [32].
| PKLNK | Accession code of the interacting protein | Name | Role |
|---|---|---|---|
| NP_009130.1 | NP_001560 | Interleukin-1 receptor-associated kinase 1 isoform 1 | Partially responsible for IL1-induced upregulation of the transcription factor NF-kappa B |
| NP_001561 | Interleukin-1 receptor-associated kinase 2 | Participate in the IL1-induced upregulation of NF-kappa B | |
| NP_002459 | Myeloid differentiation primary response gene 88 | Functions as adapter protein in the association of IL-1 receptor associated kinase (IRAK) with the IL-1 receptor | |
| NP_067681 | Toll-like receptor adaptor molecule 2 | Involved in Toll receptor siganling | |
| NP_665802 | TNF receptor-associated factor 6 | Mediates signal transduction from members of the TNF receptor superfamily and from the members of the Toll/IL-1 family | |
|
| |||
| NP_004436.1 | NP_001035090 | Myeloid/lymphoid or mixed-lineage leukemia | Regulates cell-cell adhesions downstream of Ras activation |
| NP_002077 | Growth factor receptor-bound protein 2 isoform 1 | Binds epidermal growth factor receptor. Involved in signal transduction pathway | |
| NP_002961 | Spermidine/spermine N1-acetyltransferase | Involved in the catabolic pathway of plymine metabolism | |
| NP_004084 | Ephrin B2 | Mediates developmental events, especially in the nervous system and in erythropoiesis | |
| NP_004432 | Ephrin receptor EphB1 precursor | Mediates developmental events, especially in the nervous system and in erythropoiesis | |
| NP_005179 | Cas-Br-M (murine) ecotropic retroviral transforming sequence | Adaptor protein for receptor protein-tyrosine kinases, positively regulates receptor protein-tyrosine kinase ubiquitination in a manner dependent upon its variant SH2 and RING finger domains | |
| NP_005198 | v-crk sarcoma virus CT10 oncogene homolog | Plays a role in fibroblast transformation | |
| NP_058431 | v-crk sarcoma virus CT10 oncogene homolog isoform a | Member of an adapter protein family that binds to several tyrosine-phosphorylated proteins | |
| NP_115500 | Haloacid dehalogenase-like hydrolase domain containing 2 | Hydrolase | |
|
| |||
| NP_004508.1 | AAM77350 | LIMS2 | Is a focal adhesion protein that associates with integrin-linked kinases and involved in protein-protein interactions at adhesion sites between cells and the extracellular matrix |
| BAA18998 | Paxillin gamma | A focal adhesion complex (FAC) which interacts with a wide array of molecules involved in managing the cells response to extracellular matrix components, growth factors, cell : cell interactions, and chemotatic signals. | |
| NP_000202 | Integrin, beta 2 precursor | Cell-surface protein participates in cell adhesion as well as cell-surface mediated signaling | |
| NP_000203 | Integrin beta chain, beta 3 | Participates in cell adhesion as well as cell-surface mediated signaling | |
| NP_001003828 | Parvin, beta isoform a | Actin-binding proteins associated with focal contacts | |
| NP_001744 | Caveolin 1 | Main component of the caveolae plasma membranes, links integrin subunits to the tyrosine kinase FYN which helps in cell cycle progression | |
| NP_002084 | Glycogen synthase kinase 3 beta | Involved in energy metabolism, neuronal cell development, and body pattern formation | |
| NP_002471 | Protein phosphatase 1, regulatory (inhibitor) subunit 12A | Regulates interaction of actin and myosin downstream of the guanosine triphosphatase Rho | |
| NP_002604 | 3-phosphoinositide dependent protein kinase-1 isoform 1 | Phosphorylates and activates protein kinase B alpha and p70 S6 kinase | |
| NP_004978 | LIM and senescent cell antigen-like domains 1 | Adaptor protein which may play role in integrin-mediated cell adhesion pr spreading | |
| NP_005154 | v-akt murine thymoma viral oncogene homolog 1 | Mediator of growth factor-induced neuronal survival | |
| NP_060692 | Parvin, alpha | Actin-binding protein associated with focal contacts | |
| NP_066932 | Thymosin, beta 4 | Plays a role in regulation of actin polymerization, cell proliferation, migration, and differentiation | |
| NP_071424 | Parvin, gamma | Actin-binding proteins associated with focal contacts | |
| NP_110395 | Integrin-linked kinase-associated protein phosphatase 2C | Regulates the kinase activity of integrin-linked kinase and participate in Wnt signaling | |
| NP_391987 | Integrin beta 1 isoform 1C-1 precursor | Involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response, and metastatic diffusion of tumor cells. | |
|
| |||
| NP_000171.1 | NP_000400 | Guanylate cyclase activator 1A (retina) | Activator of guanylate cyclase |
| NP_002089 | Guanylate cyclase activator 1B (retina) | Activator of guanylate cyclase | |
| NP_006263 | S100 calcium-binding protein, beta | Involved in cell cycle progression and differentiation | |
| NP_009033 | Guanylate cyclase activator 2B | Activator of guanylate cyclase receptor | |
| O75916 | Regulator of G-protein signaling 9 | Inhibits signal transduction by increasing the GTPase activity of G-protein alpha subunits, involved in phosphotransduction | |
|
| |||
| NP_003986.2 | NP_003986 | Natriuretic peptide receptor B precursor | Primary receptor for C-type natriuretic peptide, which upon ligand binding exhibits greatly increased guanylyl cyclase activity |
| NP_077720 | Natriuretic peptide precursor C | Possesses potent natriuretic, diurectic, and vasodilating activities and are implicated in body fluid homeostasis and blood pressure control | |
|
| |||
| NP_061041.2 | NP_000446 | Serine/threonine protein kinase 11 | Regulates cell polarity and functions as a tumor suppressor |
| NP_001158 | Baculoviral IAP repeat-containing protein 4 | Inhibits apoptosis through binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 | |
| NP_057373 | Calcium binding protein 39 | Calcium binding | |
| NP_663304 | Mitogen-activated protein kinase kinase kinase 7 isoform B | Mediates signal transduction induced by TGF beta and morphogenetic protein and controls variety of cell functions including transcription regulation and apoptosis | |
| NP_665802 | TNF receptor-associated factor 6 | Mediates signal transduction from members of the TNF receptor superfamily and from the members of the Toll/IL-1 family | |
|
| |||
| NP_065731.3 | NP_004636 | Coilin | The protein encoded by this gene is an integral component of Cajal bodies (also called coiled bodies). Cajal bodies are nuclear suborganelles of varying number and composition that are involved in the posttranscriptional modification of small nuclear and small nucleolar RNAs. |
| NP_036204 | CD93 antigen precursor | Involved in intercellular adhesion and in the clearance of apoptotic cells | |
| NP_689494 | SCY1-like 1 binding protein 1 | Known to interact with SCY1-like family of kinase-like proteins | |
|
| |||
| NP_001513.2 | NP_001513.2 | Guanylate cyclase 2F | Probably plays a specific functional role in the rods and/or cones of photoreceptors. |
| NP_002089 | Guanylate cyclase activator 1B (retina) | Activator of guanylate cyclase | |
|
| |||
| NP_000897.2 | NP_006249 | Protein kinase, cGMP-dependent, type I isoform 2 | Protein phosphorylation |
| NP_002512 | Natriuretic peptide precursor B preproprotein | Functions as cardiac hormone, has role in natriuresis, diuresis, vasorlaxation inhibition of rennin, and aldosterone secretion, and has a key role in cardiovascular homeostasis | |
| NP_000897 | Natriuretic peptide receptor 1 | Membrane bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides | |
| NP_006163 | Natriuretic peptide precursor A | Potent natriuretic, diuretic, and vasodilating activities and are implicated in body fluid homeostasis and blood pressure control | |
| NP_060649 | Activating transcription factor 7 interacting protein | Modulates transcription regulation and chromatin formation | |